American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6329)
  2. Solid Tumor Oncology Division (5472)
  3. Survivorship Research (1978)
  4. Genitourinary Oncology Service (1750)
  5. Surgery (1623)
  6. Epidemiology and Biostatistics (1467)
  7. GSK Faculty (1372)
  8. Population Sciences Research Program (1355)
  9. Gastrointestinal Oncology Service (1341)
  10. Hematologic Malignancies, Division of (1267)
Search Within
Formats
  1. Meeting Abstract (6252)
  2. Journal Article (2558)
  3. Editorial (72)
  4. Review (65)
  5. Guidelines (53)
  6. Correspondence (47)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6329)
  2. Solid Tumor Oncology Division (5472)
  3. Survivorship Research (1978)
  4. Genitourinary Oncology Service (1750)
  5. Surgery (1623)
  6. Epidemiology and Biostatistics (1467)

More Groups

People
  1. Robert Motzer (447)
  2. Howard Scher (334)
  3. Eileen O'Reilly (302)
  4. Leonard Saltz (283)
  5. Dean Bajorin (278)
  6. Mark Kris (252)

More People

Years
  1. 2025 (162)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8595)
  2. JCO Precision Oncology (165)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. ASCO Connection (3)

More Publications

Results (9054)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or abiraterone acetate plus prednisone (AAP) and apalutamide (Apa) after radical prostatectomy (RP)
    Meeting Abstract

    Hoffman, K. E.; Nguyen, P. L.; Rathkopf, D. E.; Zurita, A. J.; Spratt, D. E.; Dess, R. T.; Liauw, S. L.; Szmulewitz, R. Z.; Einstein, D. J.; Bubley, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Randomized trial of transperineal versus transrectal prostate biopsy to prevent infection complications
    Meeting Abstract

    Hu, J. C.; Vickers, A.; Allaf, M. E.; Ehdaie, B.; Cohen, A. J.; Ristau, B. T.; Green, D.; Han, M.; Rezaee, M.; Pavlovich, C. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Prostate Cancer Foundation (PCF) screening guidelines for prostate cancer in Black men in the United States
    Meeting Abstract

    Garraway, I.; Carlsson, S. V.; Nyame, Y. A.; Vassey, J.; Chilov, M.; Fleming, M. T.; Frencher, S. K.; George, D. J.; Kibel, A. S.; King, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • EMBARK post hoc analysis of sexual activity (SA) patient-reported outcome (PRO) measures
    Meeting Abstract

    Freedland, S. J.; Mulhall, J.; Gleave, M.; De Giorgi, U.; Saad, F.; Rannikko, A.; Ivanova, J. I.; Nasr, A.; Reisman, A.; Ganguli, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1/2 trial of oral EPI-7386 (masofaniten) in combination with enzalutamide (Enz) compared to Enz alone in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 1 (P1) results and phase 2 (P2) design
    Meeting Abstract

    Kyriakopoulos, C.; Chatta, G. S.; Laccetti, A. L.; Iannotti, N.; Sokolova, A.; Hotte, S. J.; Tutrone, R. F.; Markowski, M. C.; Nordquist, L. T.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enzalutamide combination treatment (tx) suspension in men with high-risk biochemically recurrent (BCR) prostate cancer: Outcomes from EMBARK
    Meeting Abstract

    Freedland, S. J.; Sieber, P. R.; Gleave, M.; De Giorgi, U.; Mehlhaff, B. A.; Danila, D. C.; Dunshee, C.; Lallas, C. D.; Pliskin, M.; Tang, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer
    Meeting Abstract

    Shen, F.; Kelly, W. K.; Pandit-Taskar, N.; McDevitt, T.; Smith, R.; Menard, K.; Packman, K.; Chaudhary, R.; Rupnow, B.; Yu, M. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results
    Meeting Abstract

    Herrmann, K.; Gafita, A.; De Bono, J. S.; Sartor, A. O.; Chi, K. N.; Krause, B. J.; Rahbar, K.; Tagawa, S. T.; Czernin, J.; El-Haddad, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes of men with high-risk biochemically recurrent prostate cancer who suspended enzalutamide monotherapy treatment in the phase 3 EMBARK study
    Meeting Abstract

    Shore, N. D.; Sieber, P. R.; Gleave, M.; De Giorgi, U.; Mehlhaff, B. A.; Danila, D. C.; Dunshee, C.; Lallas, C. D.; Pliskin, M.; Tang, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PRO) in patients (pts) with BRCA1/2-altered metastatic castration-resistant prostate cancer (mCRPC) receiving niraparib (NIRA) with abiraterone acetate and prednisone (AAP): Results from MAGNITUDE study
    Meeting Abstract

    Rathkopf, D. E.; Roubaud, G.; Chi, K. N.; Efstathiou, E.; Attard, G.; Olmos, D.; Small, E. J.; Saad, M.; Castro, E.; Kim, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save